Chronic hepatitis C healed by peginterferon-α and rivabirin treatment after kidney transplantation / 영남의대학술지
Yeungnam University Journal of Medicine
;
: 150-154, 2016.
Artigo
em Coreano
| WPRIM
| ID: wpr-78776
ABSTRACT
Hepatitis C virus (HCV) infection is present in a high proportion of patients with kidney transplantation. Compared with uninfected kidney transplant recipients, HCV infected kidney recipient have higher prevalence of liver disease and worse allograft survival after transplantation. Interferon monotherapy before transplantation is standard therapy for HCV-infected kidney transplant candidates. If HCV infection is discovered after transplantation, interferon monotherapy is considered due to the limited critical situation. However, in this patient, who was a kidney recipient, HCV infection was treated after kidney transplantation with peginterferon-α and rivabirin. As a result, the patient achieved sustained virologic response.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Ribavirina
/
Prevalência
/
Interferons
/
Transplante de Rim
/
Hepacivirus
/
Hepatite C Crônica
/
Aloenxertos
/
Transplantados
/
Hepatite Crônica
/
Rim
Tipo de estudo:
Estudo de prevalência
Limite:
Humanos
Idioma:
Coreano
Revista:
Yeungnam University Journal of Medicine
Ano de publicação:
2016
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS